Humira Cost in 2026: Prices & How to Save
Humira Cost in 2026: Prices & How to Save
The pharmacy tells you the Humira cost for a one-month supply is $7,800. You ask if that's a mistake. It isn't.
Brand-name Humira still carries a list price of $6,922.62 per carton of two 40 mg autoinjectors — and most retail pharmacies mark it up from there. What's changed since 2023 is everything underneath that number. Ten adalimumab biosimilars have launched in the US, cash channels have appeared that didn't exist two years ago, and the gap between the highest and lowest legitimate price for the same molecule is now larger than most people's rent.
At a glance
- Brand Humira's list price is $6,922.62 per carton (two 40 mg pens) — retail cash prices run roughly $6,400 to $8,900 a month
- The same molecule as a biosimilar can be bought for as little as $569.27 per carton through Cost Plus Drugs, and biosimilar list prices run 55%–85% below brand
- Conditions with loading doses (Crohn's, ulcerative colitis, hidradenitis suppurativa) cost 3x more in month one — up to roughly $20,700 at list price
- Brand Humira through CanAmerica Plus runs $2,815.99 for a 40 mg/0.8 mL two-pen supply, versus $6,024.22 US retail
- Adalimumab is not your only option — Enbrel, Rinvoq, and Otezla have their own cash prices worth comparing
How much does Humira cost without insurance in 2026?
Two numbers matter, and they aren't the same.
The list price (what AbbVie sets) is $6,922.62 for a carton of two 40 mg pens or syringes — the standard four-week supply for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The retail cash price is what a pharmacy actually rings up, and it's higher: GoodRx puts the average around $8,500 for two 40 mg/0.4 mL pens, with coupon prices starting near $6,380. Drugs.com reports a range of $7,000 to $13,000 per month depending on strength and pharmacy.
| What you're buying | Typical US cash price (July 2026) |
|---|---|
| Humira 40 mg/0.8 mL, 2 pens (list price) | $6,922.62 |
| Humira 40 mg/0.4 mL, 2 pens (retail average) | ~$8,500 |
| Humira 40 mg, 2 pens (GoodRx coupon, low end) | ~$6,380 |
| Humira 10 mg/0.1 mL, 2 syringes (pediatric) | ~$10,000+ |
For a chronic condition you'll treat for years, that's an annual bill north of $85,000 at list. It's the reason Humira was the best-selling drug in the world for most of the last decade.
Why the sticker price isn't what most people pay
Almost nobody pays $6,922 out of pocket. Insurers negotiate rebates that pull the net price down to roughly $2,100 per month — a figure Blue Shield of California cited publicly when it moved members to a biosimilar priced at $525 per monthly dose.
That gap between list and net is the whole game. If you have coverage, your plan pays the discounted number and you pay a copay or coinsurance. If you're uninsured, underinsured, or stuck in a high-deductible plan before it kicks in, you're quoted the number nobody else pays.
Cash-pay strategies exist precisely to close that gap.
Humira cost by condition — loading doses change the math
Most cost articles quote a single monthly number. That's only right for about half the people reading them. Dosing varies by diagnosis, and the conditions with loading doses hit you with a brutal first month.
| Condition | Starting dose | Pens needed in month 1 | Approx. list cost, month 1 |
|---|---|---|---|
| Rheumatoid / psoriatic arthritis, ankylosing spondylitis | 40 mg every other week | 2 | ~$6,923 |
| Plaque psoriasis | 80 mg once, then 40 mg every other week | 3 | ~$10,400 |
| Crohn's disease, ulcerative colitis | 160 mg day 1, 80 mg day 15, then 40 mg every other week | 6 | ~$20,770 |
| Hidradenitis suppurativa | 160 mg day 1, 80 mg day 15, then 40 mg weekly | 6+ | ~$20,770+ |
After the loading phase, most people settle into 40 mg every other week — one carton a month. But if you're starting treatment for Crohn's without coverage, budgeting for "about $7,000" leaves you $13,000 short. Ask your prescriber exactly how many pens your first month requires before you fill anything.
Humira biosimilars: what adalimumab actually costs now
Ten FDA-approved adalimumab biosimilars are on the US market: Amjevita, Cyltezo, Hyrimoz, Hadlima, Yuflyma, Yusimry, Idacio, Abrilada, Hulio, and Simlandi. Same molecule, reviewed by the FDA to show no clinically meaningful difference from Humira in structure, potency, safety, or effect. Several carry interchangeable status, which means a pharmacist can substitute them without a new prescription in most states.
Prices vary wildly — and that variation is where the money is.
| Adalimumab option | Cash price per carton (2 × 40 mg) |
|---|---|
| Yusimry via Cost Plus Drugs | $569.27 + dispensing and shipping |
| Yusimry (list price) | $995.00 |
| Hyrimoz (2024 employer claims average) | ~$1,455 |
| Amjevita (2024 employer claims average) | ~$2,655 |
| Brand Humira (list price) | $6,922.62 |
Same drug. A twelve-fold spread. Employer claims data compiled by Nomi Health found adalimumab biosimilar costs ranging from $639 to $2,655 per prescription across more than 950 self-funded employers — for products that are clinically equivalent.
Two things are worth knowing before you switch. Every biosimilar launched since 2023 is citrate-free, which removes the stinging burn that made the original Humira formulation miserable for a lot of people. And biosimilar coverage is uneven — some plans still prefer brand Humira because the rebates are richer, which is why a cash price can occasionally beat your own insurance.
Cash-pay price comparison: the honest version
Here's the full picture for a standard 40 mg every-other-week supply, as of July 14, 2026.
| Option | What you get | Cash price |
|---|---|---|
| Cost Plus Drugs (Yusimry) | Biosimilar adalimumab, 2 pens | $569.27 + fees |
| TrumpRx (brand Humira Pen) | Brand Humira 40 mg/0.4 mL, 2 pens | $950.00 |
| CanAmerica Plus | Brand Humira 40 mg/0.8 mL, 2 pens | $2,815.99 (vs $6,024.22 US retail) |
| GoodRx coupon at retail pharmacy | Brand Humira, 2 pens | ~$6,380–$8,500 |
| Retail pharmacy, no discount | Brand Humira, 2 pens | ~$7,000–$13,000 |
We're not going to pretend CanAmerica Plus is the cheapest line in that table. For adalimumab specifically, a US biosimilar bought with cash is the lowest-cost path available right now, and if your prescriber is comfortable writing for one, that's the call. Where a cash-pay network earns its place is on the drugs where no cheap US channel exists — and if you're on brand Humira and your prescriber has a clinical reason to keep you there, $2,815.99 beats retail by $3,208 a month.
Compare all of them before you fill. The worst outcome is paying $8,500 because nobody told you the other four rows existed.
Savings tip: Ask your prescriber to write for a specific biosimilar — adalimumab-aqvh, for example — rather than "Humira," and to leave off "dispense as written." A prescription that names the brand can block the pharmacy from substituting the cheaper equivalent, even where substitution is legal in your state.
What about switching off adalimumab entirely?
Sometimes the cheapest path isn't a different version of the same drug — it's a different drug. That's a conversation for your rheumatologist, dermatologist, or gastroenterologist, not something to decide from a price table. Knowing the numbers helps you have it.
- Methotrexate — still the first-line DMARD for rheumatoid arthritis, priced at $65.99 for 100 tablets of 2.5 mg through CanAmerica Plus. Many people take it alongside a biologic; some do well on it alone.
- Enbrel (etanercept) — another TNF blocker, $2,663.99 for four 50 mg SureClick injections, roughly a month's supply.
- Rinvoq (upadacitinib) — an oral JAK inhibitor, $1,799.99 for 30 tablets. No injections, different risk profile. Full breakdown in our Rinvoq cost guide.
- Otezla (apremilast) — an oral option for psoriasis and psoriatic arthritis, $1,271.99 for 56 tablets. Details in our Otezla cost guide.
Switching biologics isn't free of consequences. Anti-drug antibodies, loss of response, and a rocky transition period are all real. Cost alone is a bad reason to change a drug that's working — but it's a perfectly good reason to ask whether something else would work as well.
How to lower your Humira cost
Settle the biosimilar question first. It's the single biggest lever. A carton at $569 versus a carton at $6,923 is a difference of more than $76,000 a year.
Price the exact strength and pen count you were prescribed. The 40 mg/0.4 mL and 40 mg/0.8 mL products are priced differently at nearly every pharmacy and channel. A quote that doesn't specify which one you're getting is useless.
Check the cash price even if you have insurance. With a high deductible, coinsurance on a $7,000 drug can cost more than a $569 cash purchase outright. Cash purchases generally don't count toward your deductible, so run the full-year math, not just this month's.
Don't ration doses. Stretching Humira to save money is associated with loss of response, anti-drug antibody formation, and disease flares. If cost is why you're skipping, say so to your prescriber. There's almost always a cheaper legitimate path, and it beats undertreating the disease.
Verify any pharmacy you use. Check licensure before sending money anywhere. A price that looks impossible usually is.
The bottom line
Brand Humira costs about $6,900 at list and up to $8,900 at retail in 2026, and almost nobody needs to pay that. The same molecule sells as a biosimilar for as little as $569 per carton, brand Humira has a $950 direct cash price, and CanAmerica Plus lists brand Humira at $2,815.99 against $6,024.22 US retail.
Bring the price list to your next appointment and ask two questions: can I use a biosimilar, and can you write it in a way the pharmacy can actually fill cheaply? For the safety side of this decision, our guide to Humira side effects covers what to expect and what to watch for.
Frequently asked questions
How much does Humira cost per month without insurance?
Between roughly $6,400 and $8,900 for a standard two-pen carton of 40 mg, depending on the pharmacy and whether you use a discount coupon. The list price is $6,922.62. Pediatric strengths and conditions with loading doses cost more — Crohn's disease can run above $20,000 in the first month at list price.
Is there a generic for Humira?
Not a generic in the traditional sense — biologics get biosimilars instead. Ten FDA-approved adalimumab biosimilars are available in the US, and several are designated interchangeable, which lets a pharmacist substitute them without a new prescription. They're clinically equivalent to Humira and cost far less.
Why is Humira so expensive?
AbbVie built a patent thicket of more than 100 patents around Humira, which kept biosimilar competition out of the US market until 2023 — years after biosimilars reached Europe. Prices rose steadily during that period. Competition has since pushed biosimilar prices 55% to 85% below brand, but Humira's own list price has barely moved.
Is a Humira biosimilar as good as Humira?
The FDA requires biosimilars to show no clinically meaningful differences from the reference product in safety, purity, and potency. Real-world switching studies haven't shown a loss of efficacy. Some people do report feeling worse after a switch — an effect researchers attribute largely to nocebo response. If you switch and something feels wrong, tell your prescriber rather than stopping on your own.
Can I get Humira on a payment plan?
Some specialty pharmacies will split a fill across payments, but the terms vary and none of it changes the underlying price. Reducing what you're charged — by switching to a biosimilar, using a cash channel, or comparing pharmacies — does far more than financing it ever will.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.
